Page 25 - Technical Operations News Today

Lighter than steel brakes, with up to 700 pounds (320 kg) of weight savings per aircraft, this upgrade to the Safran Landing Systems carbon brakes configuration will help American meet its sustainability commitments by reducing its greenhouse gas (GHG) emissions by 77 tons per Boeing 737NG aircraft every year. Thanks…

NORTHAMPTON, MA / ACCESSWIRE / December 15, 2022 / The safety of our customers and team members is guided by our Safety Management System (SMS), an organizationwide approach to identifying and managing

/PRNewswire/ -- Renibus Therapeutics, Inc., ("Renibus"), a clinical-stage biotechnology company developing breakthrough products for cardiorenal diseases,...

11.12.2022 - Kite, a Gilead Company (Nasdaq: GILD), today announced results from one of the largest real-world analyses of patients who received CAR T-cell therapy assessing the impact of time from leukapheresis to infusion (vein-to-vein time) for Yescarta ...

– Kite’s Manufacturing Time for Yescarta® in the U.S. is Median of 7-Days from Start of Cell Enrichment to Harvest, with an Overall 16-Day Turnaround Time (Leukapheresis to Product Release) – – CIBMTR Analysis Finds Median ‘Vein-to-Vein’ Time (Leukapheresis to Infusion) in Real World Setting is 27-Days for Yescarta in the U.S. – – In Same Analysis, Shorter Vein-to-Vein Time Associated with 60% Complete Response Rate in Patients Treated with Yes...

Moments after the Nashville Predators discovered Bridgestone Arena had flooded due to a broken water line last week, team leaders feared the worst: no hockey in Smashville for months.

Addressing staff shortages at air traffic control facilities and stopping airlines from misusing visa programs are among the top priorities for transportation unions next year.

Online Recruitment magazine for HR Directors, Personnel Managers, Job Boards and Recruiters with information on the internet recruitment industry

United Therapeutics Corporation (NASDAQ:NASDAQ:UTHR) Q3 2022 Earnings Conference Call November 02, 2022 9:00 AM ET Company Participants Dewey Sedman – Head-Investor Relations Martine...

/PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biopharmaceutical company developing next-generation cellular immunotherapies based on induced...